Fenticonazole
Sold as Lomexin vaginal ovules, Lomexin vaginal
1-[2-(2,4-Dichlorophenyl)-2-[(4-phenylsulfanylphenyl)methoxy]ethyl]imidazole
Drag to rotate. Structure from PubChem CID 51755.
Background
Registration
- Applicants
- 2
- Registrations
- 3
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Acino Pharma (Pty) Ltd | Lomexin vaginal ovules, Lomexin vaginal | 200 mg, cream | 290053, 290055 | Not determined | None |
| Pharmaplan (Pty) Ltd | Lomexin vaginal ovules | 600 mg | 290054 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Lomexin 200 MG vaginal ovules EACH OVULE CONTAINS FENTICONAZOLE NITRATE 200 MG | 200 mg | 29005329/18.6/0053 | Registered | Not determined | None |
| Lomexin 600 MG vaginal ovules EACH OVULE CONTAINS FENTICONAZOLE NITRATE 600 MG | 600 mg | 29005429/18.6/0054 | Registered | Not determined | None |
| Lomexin vaginal cream EACH 5 g CREAM CONTAINS FENTICONAZOLE NITRATE 100 mg | Cream | 29005529/18.6/0055 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Fenticonazole
Consolidated Schedules 06 July 2026, line 6326
S3: Fenticonazole
- except when intended for application to the skin.
Consolidated Schedules 06 July 2026, line 3585
S1: Fenticonazole
- when intended for application to the skin.
Consolidated Schedules 06 July 2026, line 437
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.